Plain-English translation of NCT06815120 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This is one of the first times this treatment has been tested in people.
This trial is testing a new ureteric stent—a small tube placed in your ureter (the tube that carries urine from your kidney to your bladder)—to see if its specially designed shape can reduce infections and blockages compared to standard stents. The stent is being tested in two groups: people with kidney stones and people with cancer that is blocking their ureters. The goal is to find out whether this treatment reduces painful infections and the need for repeated hospital visits.
Current stents often develop layers of bacteria and mineral deposits that cause infections in over 90% of patients, leading to serious complications, pain, and repeated hospitalizations. This trial exists to test whether the new treatment's improved design can prevent these buildups, reduce infections, decrease pain, and help patients avoid frequent trips to the hospital.
You likely qualify if…
You likely don't qualify if…
You would receive the new ureteric stent as part of your standard clinical care during a procedure. After stent placement, you would complete questionnaires about your pain, quality of life, and any symptoms, and you may have follow-up visits to monitor how well the stent is working and whether you develop any infections. Your participation helps doctors understand whether this new stent design leads to fewer infections and complications than traditional stents.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
United Kingdom